Polymeric Biomaterials Market Size, Industry Analysis Report, Regional Outlook, Application Potential, Price Trends, Competitive Market Share & Forecast, 2021 – 2027
Report ID: GMI4041
Polymeric Biomaterials Market size is projected to experience significant growth from 2019 to 2025.
Increasing applications of polymeric biomaterials in the field of tissue engineering will augment the polymeric biomaterials market growth. Polymeric biomaterials can be fabricated into medical devices for wide range of applications such as cancer therapy, non-viral gene therapy and drug delivery. Moreover, robust growth in the field of polymer science and engineering has paved way for development of superior products that should positively impact industry growth.
Growing prevalence of chronic diseases across the globe will drive the demand for polymeric biomaterials over the coming years. The polymeric biomaterials can be of great help in such scenario. For instance, biomaterials have great potential in cardiac regeneration. They either act as substitute scaffold or drug carrier. As reported by world health organization, cardiovascular diseases are expected to be responsible for 23.6 million deaths by 2030. Rising prevalence of chronic diseases will increase adoption of polymeric biomaterials positively impacting the industry growth.
Natural polymeric biomaterials segment is predicted to witness lucrative growth over the forecast timeframe. Improved biocompatibility and biodegradability of naturally derived biomaterials can be of great help. Naturally derived biomaterials enhanced the attachment and migration of cells from the surroundings and promote tissue repair. Moreover, they have ability to support migration, proliferation and cell adhesion. Aforementioned advantages of natural polymeric biomaterials will support the segment growth over forecast timeframe.
Neurology application segment will witness robust growth over the forecast timeframe due to application of synthetic as well as natural polymers for restoring damaged neural tissues. Polymers offer wide range of flexibility in terms of mechanical characteristics, shape and possess improved biocompatibility. It can be molded into support structure that enables regeneration of neural tissues.
North America polymeric biomaterials market currently dominates the global industry and the scenario is likely to remain so over the forecast period. Increasing regional prevalence of chronic diseases such as cardiovascular and neurology diseases will drive the polymeric biomaterials’ demand. Moreover, favorable demographic trends such as aging population coupled with high healthcare expenditure will drive the regional growth in foreseeable future period.
Notable industry players in polymeric biomaterials market are Zimmer Biomet, W. L. Gore and Associates, Invibio Ltd., Royal DSM, Corbion NV, Covestro AG, and Bezwada Biomedical, LLC. Key industry players adopt strategic initiatives such as product launches, acquisitions, and mergers to sustain industry competition. Product approvals from regulatory authorities further facilitate the entry of innovative products in the industry. For instance, in April 2018, Zimmer received FDA approval for its product Persona Trabecular Metal Tibia.
Polymeric Biomaterials Market, by type, 2014-2025 (USD Million)
Polymeric Biomaterials Market, by Application, 2014-2025 (USD Million)
- Wound Care
The above information is provided for the following regions and countries:
- North America
- Asia Pacific
- South Korea
- Latin America
- Middle East and Africa
- Saudi Arabia
- South Africa
- Zimmer Biomet
- W. L. Gore and Associates
- Invibio Ltd.
- Royal DSM
- Corbion NV
- Covestro AG
- Bezwada Biomedical, LLC.
What Information does this report contain?
Customize this Report
Our Market Research Reports Include:
- Market snapshot
- Market Segmentation
- Value Chain Analysis
- Growth Dynamics
- Potential Market Opportunities
- Regulatory Overview
- Technology Evolution
- Innovation & Sustainability